4//SEC Filing
Andera Partners 4
Accession 0000899243-18-028098
CIK 0001603756other
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 7:40 PM ET
Size
24.9 KB
Accession
0000899243-18-028098
Insider Transaction Report
Form 4
BioDiscovery 4 FCPR
10% Owner
Transactions
- Conversion
Common Stock
2018-11-02+799,228→ 799,228 total(indirect: See footnote) - Conversion
Common Stock
2018-11-02+654,237→ 2,690,795 total(indirect: See footnote) - Conversion
Series B-1 Preferred Stock
2018-11-02−671,733→ 0 total(indirect: See footnote)→ Common Stock (806,080 underlying) - Conversion
Series C Preferred Stock
2018-11-02−545,197→ 0 total(indirect: See footnote)→ Common Stock (654,237 underlying) - Conversion
Common Stock
2018-11-02+806,080→ 1,605,308 total(indirect: See footnote) - Conversion
Common Stock
2018-11-02+431,250→ 2,036,558 total(indirect: See footnote) - Purchase
Common Stock
2018-11-02$15.00/sh+866,666$12,999,990→ 3,557,461 total(indirect: See footnote) - Conversion
Series A Preferred Stock
2018-11-02−345,000→ 0 total(indirect: See footnote)→ Common Stock (799,228 underlying) - Conversion
Series B-2 Preferred Stock
2018-11-02−359,375→ 0 total(indirect: See footnote)→ Common Stock (431,250 underlying)
Andera Partners
10% Owner
Transactions
- Conversion
Common Stock
2018-11-02+431,250→ 2,036,558 total(indirect: See footnote) - Purchase
Common Stock
2018-11-02$15.00/sh+866,666$12,999,990→ 3,557,461 total(indirect: See footnote) - Conversion
Series B-1 Preferred Stock
2018-11-02−671,733→ 0 total(indirect: See footnote)→ Common Stock (806,080 underlying) - Conversion
Series C Preferred Stock
2018-11-02−545,197→ 0 total(indirect: See footnote)→ Common Stock (654,237 underlying) - Conversion
Common Stock
2018-11-02+799,228→ 799,228 total(indirect: See footnote) - Conversion
Common Stock
2018-11-02+806,080→ 1,605,308 total(indirect: See footnote) - Conversion
Common Stock
2018-11-02+654,237→ 2,690,795 total(indirect: See footnote) - Conversion
Series A Preferred Stock
2018-11-02−345,000→ 0 total(indirect: See footnote)→ Common Stock (799,228 underlying) - Conversion
Series B-2 Preferred Stock
2018-11-02−359,375→ 0 total(indirect: See footnote)→ Common Stock (431,250 underlying)
Footnotes (6)
- [F1]Reflects a 1.2-for-1 forward stock split of the Issuer's common stock effected on October 18, 2018.
- [F2]Effective upon the closing of the Issuer's initial public offering of its common stock under the Securities Act of 1933, as amended, each share of Series A preferred stock automatically converted into 2.31660 shares of the Issuer's common stock. The A preferred stock had no expiration date.
- [F3]This report is filed jointly by Andera Partners ("Andera") and BioDiscovery 4 FCPR ("BioDiscovery"). 2,824,128 shares are held of record by BioDiscovery and 733,333 shares are held of record by BioDiscovery 5 ("BioDiscovery 5"). Andera is the manager of BioDiscovery and BioDiscovery 5 and may be deemed to have sole voting and dispositive power over the shares held by BioDiscovery and BioDiscovery 5.
- [F4]Effective upon the closing of the Issuer's initial public offering of its common stock under the Securities Act of 1933, as amended, each share of Series B-1 preferred stock automatically converted into 1.2 shares of the Issuer's common stock. The B-1 preferred stock had no expiration date.
- [F5]Effective upon the closing of the Issuer's initial public offering of its common stock under the Securities Act of 1933, as amended, each share of Series B-2 preferred stock automatically converted into 1.2 shares of the Issuer's common stock. The B-2 preferred stock had no expiration date.
- [F6]Effective upon the closing of the Issuer's initial public offering of its common stock under the Securities Act of 1933, as amended, each share of Series C preferred stock automatically converted into 1.2 shares of the Issuer's common stock. The C preferred stock had no expiration date.
Documents
Issuer
Axonics Modulation Technologies, Inc.
CIK 0001603756
Entity typeother
IncorporatedFrance
Related Parties
1- filerCIK 0001757283
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 8:00 PM ET
- Accepted
- Nov 2, 7:40 PM ET
- Size
- 24.9 KB